FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Roche Files De Novo App for Fertility Assay

[ Price : $8.95]

Roche files a medical device direct de novo application seeking marketing clearance for its fully automated Anti-Mullerian assay f...

FDA Needs Comprehensive IT Plan: GAO

[ Price : $8.95]

The Government Accountability Office says that FDA agrees with its recommendation that the agency define schedules and milestones ...

FDA Ends Device ISO Audit Report Pilot

[ Price : $8.95]

Federal Register Notice: FDA terminates the Medical Device ISO Voluntary Audit Report Pilot Program.

Doctor Asks FDA Action on Hypnotic Drugs

[ Price : $8.95]

Former psychiatry professor Daniel Kripke says FDA should take numerous actions to restrict use of so-called hypnotic drugs becaus...

FDA Seeks User Fees for Patient Data Reviews

[ Price : $8.95]

FDA says it needs targeted user fees for reviewing medical device submissions containing patient-reported outcome data because the...

FDA Lifts Clinical Hold on Advaxis Trials

[ Price : $8.95]

FDA lifts a clinical hold against all Advaxis INDs for three product candidates axalimogene filolisbac (formerly ADXS-HPV), ADXS-...

FDA Clears Mercks Gardasil for Older Males

[ Price : $8.95]

FDA approves a Merck supplemental BLA for Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant) to included the products...

Cardica Supports 510(k) with FDA-requested Animal Data

[ Price : $8.95]

Cardica says it has submitted FDA-requested animal study data to support its 510(k) seeking an expanded indication for its MicroCu...

Pathology Group Says FDA Ignored LDT Facts

[ Price : $8.95]

The Association for Molecular Pathology says an FDA report justifying agency oversight of laboratory-developed tests ignored facts...

FDA Drops REMS for Rosiglitazone Drugs

[ Price : $8.95]

FDA drops the REMS requirement for Type 2 diabetes drugs containing rosiglitazone.